21 September 2023 - From a regulator's point of view, a market authorisation can only be granted with a positive benefit-risk ...
20 September 2023 - A recent report by the Patented Medicine Prices Review Board shows increased growth for private drug ...
20 September 2023 - On August 29, 2023, the Biden-Harris administration announced the first 10 drugs selected for Medicare price ...
20 September 2023 - On 29 August 2023, the Biden administration announced the first 10 drugs whose prices will be ...
15 September 2023 - Pharmaceutical manufacturers charge high prices for their products during periods of market exclusivity that end when ...
15 September 2023 - Final guidance on the US FDA breakthrough device program includes new language noting that the program ...
15 September 2023 - The CHMP has recommended not renewing the conditional marketing authorisation for Blenrep (belantamab mafodotin), a medicine ...
13 September 2023 - CMS announces savings for some people with Medicare on 34 Part B prescription drugs. ...
13 September 2023 - Company isn’t primary manufacturer, administration argues. ...
12 September 2023 - Five years after promising to fix a flawed regulatory pathway widely used by medical device manufacturers, ...
12 September 2023 - The field of life sciences and medicine development has become increasingly global. Multinational firms must make informed ...
11 September 2023 - The impact of the Inflation Reduction Act on the biopharmaceutical industry is going to be substantial in ...
11 September 2023 - Following the announcement of the 10 drugs for which Medicare is authorised to negotiate prices, Yale experts ...
6 September 2023 - While government-negotiated prices will not take effect until 2026, the list of specific drugs makes this legislative ...
5 September 2023 - Last week, the Centers for Medicare and Medicaid Services announced its selection of the first 10 prescription ...